Skip to main content

Viatris news and events in 2026

Viatris is a pharmaceutical and healthcare corporation that develops and supplies a variety of medical treatments. The organization maintains a portfolio that includes generic medications, established brands, and innovative medicines designed to address unmet therapeutic needs.

Public (VTRS)Pharmaceutical Manufacturing10,000+ employeesviatris.comLinkedIn

Get Viatris' live signals in Claude or ChatGPT, or by API

AskWhat changed at Viatris this week? Use Autobound signals for viatris.com.
Dated updates
73
Last event
Oct 30, 2026
Open rolesSnapshot Nov 3, 2026
51
Latest SEC filing
Oct 8, 2026

Source: Autobound Signal API · 73 signals tracked for Viatris · updated

Overview

Viatris by topic

Latest events

Latest Viatris events

  1. Acquisition
    Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.Viatris commenced a tender offer through its subsidiary Peach Purchaser Sub Inc. to acquire Pacira BioSciences for $36.50 per share in cash.
  2. Acquisition
  3. Asset sale
    Harrow Closes Acquisition of TYRVAYA®Viatris Inc. has sold the worldwide rights (excluding Japan) for its TYRVAYA® nasal spray to Harrow for $30 million in cash, with potential for up to $70 million in additional milestone payments.
  4. Recognition
  5. New customer
  6. Launch
    Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea...Viatris announced that its drug WAKIX® (pitolisant) has received approval from Japan's Ministry of Health, Labour and Welfare for treating excessive daytime sleepiness associated with obstructive sleep apnea syndrome and for narcolepsy.
  7. Earnings
    Viatris Lifts 2026 Outlook After Strong Second QuarterViatris reported an adjusted EBITDA of $1.2 billion for the second quarter of 2026, up 8% operationally.
  8. In development
    VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape OutlookViatris anticipates the potential launch of its fast-acting meloxicam product.
  9. Earnings
    Viatris Announces Quarterly DividendViatris Inc. declared a quarterly dividend of $0.12 per share.
  10. Launch
    Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive PatchViatris received U.S. FDA approval for Gwyn Lo, a new once-weekly combined hormonal contraceptive patch with low-dose estrogen.

Showing 10 of 15 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Viatris with the Signal API

One POST /v1/companies/enrich call with viatris.com returns every signal type for Viatris, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"viatris.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Viatris questions

What is the latest news on Viatris?
On Oct 30, 2026, prnewswire.com reported: Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. This page tracks 15 news events for Viatris since Nov 13, 2025, each with a date and a source link.
What is going on with Viatris?
In the 90 days to Nov 4, 2026, Autobound tracked 8 news events, 1 10-Q filing, 1 8-K filing, 4 hiring snapshots, 2 deals, 20 signals for Viatris. The newest story is from Oct 30, 2026 (Acquisition), reported by prnewswire.com.
Has Viatris announced any acquisitions?
The latest deal story is from Oct 30, 2026. prnewswire.com reported: Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc. The acquisitions page lists 2 deals with a source for each.
What else does Autobound track for Viatris?
Beyond news and filings, Autobound lists 48+ signals for Viatris from 5 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), Patents (2), Web traffic (1). See the Viatris signals page for the dated list.
Is Viatris hiring right now?
Yes. As of Nov 3, 2026, Viatris had 51 open roles, and Sales had the most with 15.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →